Tower Research Capital (TRC)’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71K | Buy |
1,964
+666
| +51% | +$580 | ﹤0.01% | 4758 |
|
|
2025
Q1 | $2.22K | Sell |
1,298
-784
| -38% | -$1.34K | ﹤0.01% | 4576 |
|
|
2024
Q4 | $4.37K | Buy |
2,082
+738
| +55% | +$1.55K | ﹤0.01% | 4473 |
|
|
2024
Q3 | $4.1K | Sell |
1,344
-2,026
| -60% | -$6.18K | ﹤0.01% | 4673 |
|
|
2024
Q2 | $9.37K | Buy |
3,370
+668
| +25% | +$1.86K | ﹤0.01% | 4260 |
|
|
2024
Q1 | $9.81K | Sell |
2,702
-3,107
| -53% | -$11.3K | ﹤0.01% | 3787 |
|
|
2023
Q4 | $7.26K | Sell |
5,809
-2,521
| -30% | -$3.15K | ﹤0.01% | 4638 |
|
|
2023
Q3 | $8.33K | Sell |
8,330
-2,621
| -24% | -$2.62K | ﹤0.01% | 4362 |
|
|
2023
Q2 | $7.99K | Buy |
10,951
+6,862
| +168% | +$5.01K | ﹤0.01% | 4466 |
|
|
2023
Q1 | $11K | Sell |
4,089
-935
| -19% | -$2.52K | ﹤0.01% | 4232 |
|
|
2022
Q4 | $12K | Buy |
5,024
+1,396
| +38% | +$3.33K | ﹤0.01% | 3723 |
|
|
2022
Q3 | $9K | Buy |
+3,628
| New | +$9K | ﹤0.01% | 4665 |
|
|
2022
Q2 | – | Sell |
-3,056
| Closed | -$10K | – | 6330 |
|
|
2022
Q1 | $10K | Buy |
3,056
+1,852
| +154% | +$6.06K | ﹤0.01% | 4318 |
|
|
2021
Q4 | $5K | Buy |
+1,204
| New | +$5K | ﹤0.01% | 5163 |
|
|
2021
Q3 | – | Sell |
-251
| Closed | -$2K | – | 5979 |
|
|
2021
Q2 | $2K | Buy |
+251
| New | +$2K | ﹤0.01% | 5051 |
|